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Better Colon Cancer Care for Extremely Poor
Canadian Women Compared with American
Women
Kevin M. Gorey, Isaac N. Luginaah, Emma Bartfay, GuangYong Zou, Sundus Haji-Jama,
Eric J. Holowaty, Caroline Hamm, Sindu M. Kanjeekal, Frances C. Wright,
Madhan K. Balagurusamy, and Nancy L. Richter
Extremely poor Canadian women were recently observed to be largely advantaged on most
aspects of breast cancer care as compared with similarly poor, but much less adequately
insured, women in the United States. This historical study systematically replicated the pro-
tective effects of single- versus multipayer health care by comparing colon cancer care
among cohorts of extremely poor women in California and Ontario between 1996 and
2011. The Canadian women were again observed to have been largely advantaged. They
were more likely to have received indicated surgery and chemotherapy, and their wait times
for care were signiﬁcantly shorter. Consequently, the Canadian women were much more
likely to experience longer survival times. Regression analyses indicated that health insur-
ance nearly completely explained the Canadian advantages. Implications for contemporary
and future reforms of U.S. health care are discussed.
KEYWORDS: colon cancer; health care reform; health insurance; poverty; single-payer system
Both the poor and the uninsured populationsof the United States rose to approximately50 million during the Great Recession of
2007 to 2011 (DeNavas-Walt, Proctor, & Smith,
2012). In concert with presidential advocacy, these
social forces seemed critical in enabling passage of
the Patient Protection and Affordable Care Act,
so-called Obamacare, in 2010. Although Obama-
care is bound to make health care more accessible
for millions of Americans, it does not guarantee care
for all. In fact, the Congressional Budget Ofﬁce
(2012) estimated that it will leave 25 million Ameri-
cans uninsured and millions more underinsured.
Canada seems of particular comparative interest. Its
poverty rate did not increase during the Great
Recession (Murphy, Zhang, & Dionne, 2012), and
all Canadians are insured for medically necessary
care by a single, public payer.
NASW (2009) in coalition with others
(Healthcare-Now, 2013), has long advocated for
single-payer reform of U.S. health care, and their
advocacy on behalf of the uninsured continues.
Debates about the difference Obamacare is likely
to make compared with the difference that might
be realized by single-payer reform also continue.
We think that historical comparative studies of
U.S. and Canadian health care can begin to resolve
these debates. This study aims to advance such
knowledge by examining evidence on a telling
health care indicator among key informative popu-
lations: colon cancer care among women who
lived in the poorest neighborhoods of America or
Canada before Obamacare.
EXTREMELY POOR NEIGHBORHOODS IN THE
UNITED STATES AND CANADA
Four of every 100 Americans live in extremely poor
neighborhoods where 30 percent to 40 percent or
more of the people are poor. Places of prevalent
vulnerability, they are particularly distressed as a
result of their lack of social and economic capital
(Jargowsky, 2005; Kawachi, 1999; Wilson, 2012).
Adequate health insurance (HI) is also commonly
lacking among those who live in the poorest of
America’s neighborhoods, especially those who
may need it the most, such as those with illnesses
like colon cancer that can require very costly care
(Gorey et al., 2012; Shankaran, Jolly, Blough, &
Ramsey, 2012). Less is known about high-poverty
neighborhoods in Canada, not surprisingly, as they
are less prevalent and seem to be less deeply poor
places than in the United States (Chen, Myles, &
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Picot, 2012). They do exist though. In fact, two of
every 100 Ontarians live in very poor neighborhoods
(Gorey, 1998; Statistics Canada, 2002). Though the
cancer risks that Canadians are exposed to there are
probably similar to those of their U.S. counterparts
(Gorey, Holowaty, Laukkanen, Fehringer, & Rich-
ter, 1998;Krieger et al., 2002), they have one distinct
advantage: All enjoy access to health care. Therefore,
comparisons between Canada and the United States
with regard to colon cancer care among the poor
may help to clarify any disadvantaging effects of
being uninsured or underinsured in America.
COLON CANCER CARE IN POOR U.S.
AND CANADIAN NEIGHBORHOODS
Colon cancer care seems a sentinel health care per-
formance indicator. The second most common
cause of cancer death in North America, its prog-
nosis can be good with early diagnosis and treat-
ment (Canadian Cancer Society, 2009; Edwards
et al., 2010). And it may be particularly instructive
for Canada–U.S. comparisons among women for
these reasons. First, low-income status has been
consistently observed to be inversely associated
with colon cancer care in the United States, but
not in Canada (Gorey, Luginaah, Bartfay, Fung,
Holowaty, Wright, Hamm, & Kanjeekal, 2011;
Booth, Zhang-Salomons, & Mackillop, 2010;
Etzioni, El-Khoueiry, & Beart, 2008; Lima, Yasui,
Scarfe, & Winget, 2011; Rayson, Urquhart, Cox,
Grunfeld, & Porter, 2012). Second, in the United
States, people with private HI or Medicare cover-
age are more likely to receive the best, evidence-
based care and to survive longer than are those
with arguably less adequate Medicaid coverage or
no coverage (Boland et al., 2013; Bradley, Given,
Dahman, & Fitzgerald, 2008). Third, being poor,
uninsured or Medicaid insured are all much more
common among women than men in the United
States (Gorey et al., 2012; DeNavas-Walt et al.,
2012; Iceland, 2013). And fourth, HI has recently
been found to substantially buffer the disadvantag-
ing effects of poverty on colon cancer treatment
and survival among women, but not men, in
California (Gorey et al., 2012). Colon cancer care
seems quite sensitive to the sorts of social policy
forces that probably determine much of the
income and HI inequities, particularly among
women, in North America.
Extremely poor Canadian women were recently
observed to be largely advantaged on most aspects
of breast cancer care as compared with similarly
poor, but much less adequately insured, women in
the United States (Gorey et al., 2013). We are
unaware of any study that compared colon cancer
care between extremely poor Canadian and Ameri-
can women. This systematic replicating study does
so. Hypotheses were as follows: Canadian women
with colon cancer who live in high-poverty neigh-
borhoods will be advantaged on evidence-based
care and survival compared with their U.S. counter-
parts, advantages for Canadians will be greater when
compared with inadequately insured Americans
(uninsured or Medicaid insured), and advantages
among Canadians will be mediated or explained by
the intermediate effect of their all having HI.
METHOD
Sampling the Historical Cohorts
This study’s sampling frame combined Ontario and
California cancer registries (OCR, CCR), which
comprehensively and validly monitor the most
populous Canadian province and U.S. state (Gorey,
Luginaah, Bartfay, Fung, Holowaty, Wright,
Hamm, & Kanjeekal, 2011). It secondarily analyzed
the high-poverty strata of a California–Ontario
colon cancer database that originally included high-,
middle-, and low-poverty neighborhoods. Women
with colon cancer were randomly selected between
1996 and 2000 from three geographic strata in
Ontario and California: large urban areas, smaller
urban areas, and rural areas. They were followed
until 2011. Data were collected on stage of disease at
diagnosis and treatments from health records to aug-
ment the OCR. Given the costs, we sampled 300
women from high-poverty neighborhoods in
Ontario. We oversampled 1,000 women from such
neighborhoods in California. Oversampling costs
were negligible as all study variables were routinely
coded by the CCR. The California participants
served as multiple “controls” for the Ontario partici-
pant “cases” in a ratio of 3 to 1. This study was pow-
ered (80 percent) to detect rate differences of 10
percent at a signiﬁcance of 5 percent (Fleiss, Levin,
& Paik, 2003; Hennessy, Bilker, Berlin, & Strom,
1999).
High-Poverty Cohort Deﬁnitions
Similar deﬁnitions of poverty are used by Statistics
Canada and the U.S. Census Bureau, but the U.S.
threshold is more severe (Osberg, 2000). After link-
ing women with colon cancer in California to the
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2000 census according to their residential census
tract (CT), a sample was randomly selected from
CTs in which 30 percent or more of the households
met the federal poverty criterion (range = 30.0 per-
cent to 100 percent, median = 36.8 percent; U.S.
Census Bureau, 2002). A sample was similarly
selected from the poorest Ontario CTs (range =
15.0 percent to 52.8 percent, median = 22.7 per-
cent; Statistics Canada, 2002). The median annual
household incomes in U.S. dollars (Bank of Canada,
2013) were similar for the California ($22,875) and
Ontario ($22,175) cohorts.
Cancer Registry Variables
Variables coded by the CCR or by our research
team to augment the OCR were stage of disease at
diagnosis (localized stage I to metastasized stage IV),
receipt of surgery and chemotherapy, number of
regional lymph nodes harvested, wait times from
diagnosis to surgery and from surgery to chemo-
therapy, and survival time. Stage, treatment, and
survival variables all had less than 3 percent missing
data. Agreements were high among three health
record technicians who collected the augmenting
data in Ontario. Interrater assessments of 50 ran-
domly sampled health records found κ coefﬁcients
of 0.88 to 0.96 across variables. In California, pri-
mary HI status was uninsured (11.6 percent), Med-
icaid (15.0 percent), Medicare (32.1 percent), or
private (41.3 percent). Given our oversampling of
poor neighborhoods, the low representation of the
uninsured may seem surprising. Note that colon
cancer care typically takes place in hospitals where
social workers, in addition to their provision of
psychosocial support, information, referral, coordi-
nation, and advocacy services throughout cancer
treatment and follow-up, work to connect unin-
sured people to any additional resources such as
Medicaid or Medicare for which they may be
qualiﬁed.
Statistical Analyses
Clinical practice guidelines of the American Society
of Clinical Oncology and Cancer Care Ontario
were used in comparing treatment rates between
the two cohorts (Benson et al., 2004; Jonker, Spith-
off, Maroun, & Gastrointestinal Cancer Disease Site
Group, 2008). Rates were directly adjusted for age
and tumor grade and reported as percentages. Then
standardized rate ratios (RRs) were reported for
between-country comparisons, with 95 percent
conﬁdence intervals (CI) derived from the chi-square
test. Logistic regression models tested hypotheses
about mediating effects of HI on country–survival
relationships. We estimated odds ratios (ORs) and 95
percent CIs and imputed missing data from full mod-
els. Binary survival outcomes (survived a certain
number of years or not) that were best predicted
were reported (Hosmer & Lemeshow, 2000). We
ran logistic regression models that included the fol-
lowing predictors: country alone; country and HI;
country, HI, and disease stage; and country, HI,
stage, and treatments. These, respectively, assessed
the signiﬁcance of Canadian advantages; their medi-
ation by HI; and the main and mediating effects of
diagnoses, investigations, and treatments. This
study was reviewed and cleared by the University
of Windsor research ethics board. Other methodo-
logical details have been reported (Gorey, Lugi-
naah, Bartfay, Fung, Holowaty, Wright, Hamm, &
Kanjeekal, 2011, Gorey, Luginaah, Bartfay, Fung,
Holowaty, Wright, Hamm, Kanjeekal, & Balagur-
usamy, 2011,Gorey et al., 2012, 2013).
RESULTS
Description of Canadian Colon Cancer Care
Advantages
Survival Rates. Comparisons of survival rates
between the cohorts of women with colon cancer
in high-poverty neighborhoods of California and
Ontario are displayed at the top of Table 1. Overall
seven-year survival rates were signiﬁcantly greater
in Ontario (RR= 1.16), and as hypothesized, this
advantage was much greater when compared with
overall survival among uninsured or Medicaid
insured women in California (RR = 1.45). In fact,
the women with colon cancer in Ontario (44.6
percent) were nearly 50 percent more likely to
survive than were their inadequately insured coun-
terparts in California (30.7 percent). A cancer-
speciﬁc survival analysis revealed a very similar
Canadian advantage (RR= 1.46; 95 percent CI,
1.12, 1.90; data not shown). Anecdotally, we
found no signiﬁcant between-country survival dif-
ferences among men in this study’s preliminary
design phase.
Diagnoses and Treatments. The women in Cali-
fornia and Ontario were equally unlikely to have
been diagnosed early. Their rates of stage I disease at
diagnosis were 21.6 percent and 20.7 percent,
respectively (RR= 0.96; 95 percent CI, 0.75,
1.22). Overall, there was not a between-country
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difference on the receipt of surgical resection, which
was received in nearly all instances for which it was
indicated. However, 7 percent fewer of the unin-
sured women in California received surgical treat-
ment of their colon cancers (RR= 1.07). Of course,
there are legitimate reasons for refusing surgery. But
the overall surgery refusal rate of 14.8 percent among
the very few women who did not have surgery did
not differ signiﬁcantly between countries [χ2(1,
N= 27) = 0.37, p= not statistically signiﬁcant].
Adjuvant chemotherapy, typically indicated after
surgery for people with stage III disease to further
assist in the elimination of cancer cells, is displayed
next in Table 1. There was no overall difference
between the cohorts. However, the Ontario che-
motherapy rate (45.1 percent) was nearly 50 percent
greater than the rate among the uninsured or Medic-
aid insured in California (30.2 percent, RR= 1.49).
Chemotherapy for stage II colon cancer, experimen-
tal at the time of this study, was not associated
with country. It was not commonly received by
poor women in California (18.4 percent) or
Ontario (18.2 percent; RR= 0.99; 95 percent CI,
0.90, 1.09).
Various long wait times for treatment may be asso-
ciated with colon cancer recurrences, metastases, or
shorter survival. An exemplary one is displayed at the
bottom of Table 1. Overall, the women in Ontario
were less likely than the women in California to have
waited two months or more between their surgery
and receipt of adjuvant chemotherapy (20.0 percent
versus 37.7 percent, RR= 0.53). As hypothesized,
adequately insured women in California did not dif-
fer signiﬁcantly from Ontario women with regard to
long waits, but the inadequately insured in California
were much more likely to experience them (59.8
percent, RR= 0.33). The women in California
(10.7 percent) and Ontario (11.2 percent) were
equally unlikely to have experienced waits of a
month or more for surgery (RR= 1.05; 95 percent
CI, 0.45, 2.43).
Canadian Advantages Explained by HI
Two distinct, practically signiﬁcant survival analy-
ses are displayed in Table 2: (1) 10-year survival
among women with nonmetastasized disease and
(2) eight-year survival among women with nonlo-
calized and nonmetastasized disease. Such treatable
colon cancers tend to entail the most clinical and
managerial discretion. In both instances, model 1
demonstrated signiﬁcant Canadian survival advan-
tages (respective ORs of 1.48 and 1.38) that, as
hypothesized, were mediated by the positive effects
of having adequate health insurance in model 2
(respective ORs of 1.72 and 1.75). Signiﬁcant
main effects of early diagnosis (model 3), thorough
lymph node evaluation, and treatment access
(model 4) were entered into regressions in
Table 1: Significant Differences between Female Residents of California and Ontario’s




Care Characteristic and Primary Insurer Sample Ratea Sample Ratea RR 95% CI
Overall seven-year survival 975 38.4 289 44.6 1.16 1.00, 1.35
Private or Medicare 802 39.8 1.12 0.96, 1.30
Uninsured or Medicaid 173 30.7 1.45 1.14, 1.85
Stage II or III disease
Had surgical resection 569 97.2 164 97.6 1.00 0.97, 1.03
Any insurance 525 97.3 1.00 0.97, 1.04
Uninsured 1.07 1.00, 1.14
Stage III disease
Received chemotherapy 241 43.6 78 45.1 1.03 0.83, 1.28
Private or Medicare 187 44.0 1.02 0.88, 1.18
Uninsured or Medicaid 54 30.2 1.49 1.00, 2.25
Received chemotherapy for stage II or III disease
60+ days wait postsurgery 229 37.7 55 20.0 0.53 0.32, 0.88
Private or Medicare 172 32.3 0.62 0.36, 1.07
Uninsured or Medicaid 57 59.8 0.33 .20, 0.55
Notes: Bolded RRs are statistically significant. Rates were adjusted for age and tumor grade. RR = rate ratio; CI = confidence interval.
aAdjusted rates per 100 reported as percentages.
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temporal order. Early diagnosis and more thor-
ough lymph node evaluation each strongly pre-
dicted 10-year survival. These diagnostic and
investigative effects seemed to be similar in both
countries as there were no signiﬁcant Stage ×
Country or Investigation × Country interactions.
A similar pattern was observed for the prediction
of eight-year survival by early diagnosis and che-
motherapy receipt. We also analyzed predictors of
three-year survival among 260 women with
metastasized disease (data not shown). Neither
country nor health insurers were predictive. Only
palliative chemotherapy receipt entered the regres-
sion model (OR = 3.95; 95 percent CI, 1.37,
11.36) and predicted survival.
DISCUSSION
Using colon cancer care as a policy indicator, we
found modest support for our hypothesis that,
overall, extremely poor Canadian women were
advantaged in the years before Obamacare. They
were slightly more likely than their U.S. counter-
parts to enjoy relatively long survival of up to seven
years after their diagnosis. However, we found
strong and consistent support for our hypothesis
that advantages among extremely poor Canadian
women would be greater when compared with
inadequately insured Americans. Extremely poor
Canadian women seemed largely advantaged
across the colon cancer care continuum. They
were much more likely to receive chemotherapy
when it was most indicated, and they were much
more likely to survive longer than inadequately
insured Americans. Contrary to contemporary
political rhetoric, the Canadian women were even
much less likely than the American women to
experience long waits for care.
There were some null ﬁndings. No between-
country differences were observed for stage of disease
at diagnosis or for the receipt of chemotherapy for
stage II disease. Even these null ﬁndings seemed to
provide discriminant validation of the theory that HI
adequacy explains the observed Canadian advan-
tages. Study participants were diagnosed during the
1990s. At that time, colon cancer screening had only
begun to proliferate. Respectively, less than one in
four or ﬁve eligible Californians or Ontarians were
screened for colon cancer during that time (Ganz
et al., 2005; Rabeneck & Paszat, 2004). Similarly,
chemotherapy for stage II colon cancer was experi-
mental at that time. Consequently, HI gradients or
Canada–United States differences on these aspects of
colon cancer care were not expected nor observed.
Finally, our third hypothesis was validated by
two mathematical models of relatively long-term
survival of treatable colon cancer. Both models sup-
ported our hypothesis that HI mediates between-
country differences in colon cancer survival. Survival
advantages among Canadian women were largely
explained by their much better HI coverage.
Population Signiﬁcance of Health
Care Policy
This study’s key between-country differences esti-
mated with standardized RRs or adjustedORs con-
verged at about 1.50. They clearly indicated large
advantages for Canadians compared with inade-
quately insured Americans. But attributions of risks
Table 2: Associations of Characteristics with Long-Term Survival amongWomen Less than
80 Years of Agewith Treatable Colon Cancers: Logistic RegressionModels
Model 1 Model 2 Model 3 Model 4
Characteristic OR 95% CI OR 95% CI OR 95% CI OR 95% CI
10-Year Survival among 687 Women with Nonmetastasized Disease
Country (Canadian advantage) 1.48 1.02, 2.16 1.31 0.89, 1.94 1.27 0.85, 1.89 1.18 0.77, 1.83
Medicare or private insurance 1.72 1.09, 2.69 1.88 1.18, 2.98 1.81 1.12, 2.90
Stage I disease at diagnosis 2.91 1.96, 4.33 2.94 1.95, 4.41
16 or more lymph nodes harvested 1.59 1.02, 2.48
Eight-Year Survival among 506 Women with Stage II or III Disease at Diagnosis
Country (Canadian advantage) 1.38 1.00, 1.90 1.24 0.78, 1.96 1.34 0.84, 2.15 1.35 0.86, 2.15
Any insurance 1.75 1.01, 3.03 2.16 1.06, 4.41 2.23 1.10, 4.55
Stage II disease at diagnosis 2.02 1.39, 2.95 2.24 1.50, 3.36
Received chemotherapy 1.39 1.01, 2.19
Notes: All effects were adjusted for age, tumor grade and place (large or small, urban or rural). Bolded odds ratios (ORs) are statistically significant. The findings of overall (all-cause)
and cancer-specific survival analyses were nearly identical. Overall survival analyses are presented in the table. CI = confidence interval. Surgical and chemotherapy treatment rates
were significantly lower among participants 80 years of age or older in both countries.
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or preventive potentials at the population level are
functions of three factors of which the magnitude of
the between-group difference is only 1. It is also
important to consider the size of the population at
risk as well as the prevalence of exposures to the risk
or protective factors being studied. In this instance,
the central exposure or risk factor to be mediated is
a social one, poverty. The other social exposure of
interest is the risk of being inadequately insured.
Nearly 70,000 American women are diagnosed
with colon cancer each year (U.S. Cancer Statistics
Working Group, 2010), and regrettably, they
remain very commonly exposed to poverty and HI
inadequacy. Applying this study’s effects to these
parameters, it can be straightforwardly estimated
(Greenland, 2008) that tens of thousands more of
the American women received suboptimum treat-
ment and died prematurely during this study’s
15-year time span than probably would have if they
had enjoyed access to a single-payer system of health
care like Canada’s. Obamacare will surely begin to
close such between-country care gaps. However,
given the substantial inadequately insured popula-
tion that will probably remain in America (CBO,
2012), some care and survival gaps are likely to
remain. This study strongly suggests that single-
payer reform of U.S. health care would serve to fur-
ther close such gaps.
Potential Limitations
One may wonder if the ethnic compositions of
high-poverty neighborhoods, rather than their
concentrations of the poor, accounted for the
observed colon cancer care inequities. We think
not, for these reasons. First, although the OCR
does not code ethnicity, key ﬁndings were replica-
ble by conservatively comparing the subsample of
non-Hispanic white women in California with the
entire ethnically diverse sample in Ontario. For
example, the large Canadian advantage on chemo-
therapy receipt remained even when we excluded
all members of any ethnic minority group that
comprised more than half of the California sample:
non-Hispanic African (23.3 percent), Hispanic
(23.7 percent), and Asian or Paciﬁc Islander Amer-
icans (9.2 percent). And the substantial rate of sub-
optimum chemotherapy among inadequately
insured women of color in California did not differ
signiﬁcantly from that of their non-Hispanic white
counterparts. The disadvantaging effects of being
inadequately insured seem quite similar for all poor
American women with colon cancer, whether
they are majority white or minority women of
color. Ethnicity seems clearly not to confound this
study’s ﬁndings about colon cancer care among the
poor of Canada and the United States.
Does this mean that ethnicity or race does not
matter? It unequivocally does not. Recall that a
population’s risk is a function not only of effect
magnitude, but also of the size of the population at
risk and the prevalence of its exposure to risks.
Women of color comprised more than half of the
sample of the poor women with colon cancer in
California, and compared with non-Hispanic white
women, they were more than twice as likely to be
uninsured or Medicaid insured (27.8 percent versus
13.1 percent). This suggests that, in California and
other diverse U.S. states, six to seven out of every
10 of the suboptimum treatment plans and prema-
ture deaths due to colon cancer among poor
women are experienced by women of color (Galea,
Tracy, Hoggatt, DiMaggio, & Karpati, 2011; Steen-
land & Armstrong, 2006). Although the disadvan-
taging effects of being inadequately insured are
similar for all poor American women, because
women of color are both more likely to be poor
and inadequately insured, they are much more likely
than non-Hispanic white women to experience the
injustices of contemporary U.S. health care. Race
still matters in U.S. health care (West, 1993).
The cancer registries studied did not code comor-
bid conditions, but they did code causes of death.
As a result, this study’s analyses did not directly
account for potential confounding by comorbidities
that are well known to be associated with both soci-
oeconomic factors and mortality (Etzioni et al.,
2008). But they did indirectly account for them.
Recall that overall survival analyses were replicated
with cancer-speciﬁc analyses that accounted for
competing causes of death such as those primarily
caused by comorbid heart, lower respiratory, and
cerebrovascular diseases. In addition, Canadian and
American women with similar disease stages were
compared and through mathematical modeling,
essentially matched on a proxy of cancer virulence;
tumor grade; and a correlate of other chronic dis-
eases, age. Therefore, the two groups seemed to be
quite similarly diseased, making comorbid alterna-
tive explanations unlikely.
This study could also be limited by incomplete
information on chemotherapy. Because chemother-
apy is most often received in an outpatient setting, it
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can be more challenging for cancer registries to sur-
vey. For the following reasons, we think that incom-
plete information on chemotherapy or missing
chemotherapy data is not a potent alternative expla-
nation. First, the CCR data on chemotherapy were
demonstrated to be mostly complete (81 percent to
84 percent across regions) during the time that this
study’s participants were being treated, and errors
have been demonstrated not to differ by income
(Cress et al., 2003;Mallin et al., 2013). Second, miss-
ing chemotherapy data were infrequent and did not
differ between this study’s Ontario and California
cohorts. Third, analyses of insurers, hospital-based
surgeries, and survival were unlikely to have been
affected (Chan, Gomez, O’Malley, Perkins, & Clark,
2006; Hall, Schulze, Groome, Mackillop, & Holo-
waty, 2006; Li, King, deGara, White, & Winget,
2012; Mallin et al., 2013; Verrill, 2010), and any
modest errors very likely did not differ by socioeco-
nomic factors (Chan et al., 2006). Such modest
nondifferential errors on exposures, mediators, or
outcomes suggest that any bias of ﬁndings would
probably have been toward the null (Blakely,
McKenzie, & Carter, 2013; Copeland, Checkoway,
McMichael, & Holbrook, 1977; Jurek, Greenland,
& Maldonado, 2008). That is, the magnitude of this
study’s observed Canadian advantages on colon can-
cer care and survival, as well as their mediation by
HI, may all be slight underestimates.
CONCLUSION
Extremely poor women with colon cancer receive
much better care and are much more likely to survive
in Canada than in the United States. Prevalent HI
inadequacies in America versus universal, single-payer
coverage in Canada largely explain this between-
county divide. Obamacare will probably substan-
tially reduce such inequities, but single-payer reform
would probably further reduce if not completely
eliminate them.
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